Clinical Analysis of Radiotherapy for Esophageal Carcinoma with Supraclavicular Lymph Node Metastasis

GUO Xiao-mao,MEI Xin,ZHAO Kuai-le,SHI Xue-hui
DOI: https://doi.org/10.3969/j.issn.1673-5269.2005.20.013
2005-01-01
Abstract:OBJECTIVE:To analyze the factor affecting the results and the prognoses of radiotherapy for esophageal carcinoma with supraclavicular lymph node metastasis. METHODS: sixty-four primary esophageal carcinoma patients with supraclavicular lymph node metastasis were studied. The median follow-up time was 34 months (3-80 months). Thirty-three patients were found metastasis of supraclavicular lymph nodes after primary esophageal carcinoma had been treated, and 31 patients were found the metastasis when they were diagnosed. All patients were treated with the conventional radiotherapy. The total dose was 36-70 Gy/5-7 w, 1.8-2.0 Gy/d of the supraclavicular field. Forty-three patients were treated with radiotherapy alone, 16 patients were treated with radiotherapy followed by chemotherapy, and 5 ones were combined with thermotherapy. RESULTS: Of the 64 patients, complete regression (CR) was achieved in 23(39.5%); partial regression (PR) was achieved in 30(46.9%). The 1-, 3- and 5-year survival rates were 56.3%, 9.4%, 3.1%, respectively with the median survival time of 13.5 months. Thirty-seven patients (57.8%) died within the follow-up period, and 15 patients survived with disease-free, 7 ones survived with the neoplasm. Multivariate analysis showed that the diameter of supraclavicular metastasis lymph node (P=0.001), whether one side supraclavicular lymph node metastasis or both of two sides (P=0.015), and the number of supraclavicular lymph node metastasis (P=0.042) showed the statistical significant for the result of CR after radiotherapy, but only the diameter of supraclavicular metastasis lymph node was independent factor influencing the survival, P=0.010. CONCLUSIONS: The patients of esophageal carcinoma with supraclavicular lymph node metastasis can get some therapeutic efficacy with advanced radiotherapy, but combined therapy can not, improve the survival rate.
What problem does this paper attempt to address?